| 創建日期 | 上市日期 | 董事長 | 總經理 |
|---|---|---|---|
| 56/06/30 | 84/12/12 | 范滋庭 | 范滋庭 |
| EPS | 本益比 | 股價淨值比 | 現金殖利率 |
| 1.33(Q2) | 13.13 | 2.36 | 3.94% |
| 實收資本額 | 已發行普通股 | ||
| 1,786,960,890 | 178,696,089 | ||
| 主要經營業務 | |||
| 人用藥品健康食品 | |||
| 公司網址 | |||
| standard.com.tw | |||
生達(1720) 月營收報表
| 年度/月份 | 營業收入（單位：千元） | 累計營業收入（單位：千元） | |||||
|---|---|---|---|---|---|---|---|
| 單月營收 | 去年同月營收 | 單月月增率 | 單月年增率 | 累計營收 | 去年累計營收 | 累積年增率 | |
| 2023/08 | 585,898 | 509,036 | 3.9% | 15.1% | 4,151,805 | 3,690,531 | 12.5% |
| 2023/07 | 563,910 | 462,839 | 13.6% | 21.8% | 3,565,907 | 3,181,495 | 12.1% |
| 2023/06 | 496,451 | 545,007 | -3.9% | -8.9% | 3,001,996 | 2,718,656 | 10.4% |
| 2023/05 | 516,803 | 505,470 | 4.3% | 2.2% | 2,505,546 | 2,173,648 | 15.3% |
| 2023/04 | 495,723 | 430,810 | -9% | 15.1% | 1,988,743 | 1,668,178 | 19.2% |
| 2023/03 | 544,635 | 433,700 | 19.7% | 25.6% | 1,493,020 | 1,237,368 | 20.7% |
| 2023/02 | 454,878 | 322,740 | -7.8% | 40.9% | 948,385 | 803,669 | 18% |
| 2023/01 | 493,507 | 480,929 | -5.6% | 2.6% | 493,507 | 480,929 | 2.6% |
| 2022/12 | 522,557 | 480,171 | -2.8% | 8.8% | 5,851,557 | 4,604,072 | 27.1% |
| 2022/11 | 537,613 | 393,206 | 2.7% | 36.7% | 5,329,000 | 4,123,901 | 29.2% |
| 2022/10 | 523,622 | 359,643 | -9.3% | 45.6% | 4,791,387 | 3,730,695 | 28.4% |
| 2022/09 | 577,234 | 382,901 | 13.4% | 50.8% | 4,267,765 | 3,371,052 | 26.6% |
| 2022/08 | 509,036 | 379,426 | 10% | 34.2% | 3,690,531 | 2,988,152 | 23.5% |
| 2022/07 | 462,839 | 358,516 | -15.1% | 29.1% | 3,181,495 | 2,608,726 | 22% |
| 2022/06 | 545,007 | 315,438 | 7.8% | 72.8% | 2,718,656 | 2,250,210 | 20.8% |
| 2022/05 | 505,470 | 443,535 | 17.3% | 14% | 2,173,648 | 1,934,772 | 12.3% |
| 2022/04 | 430,810 | 390,132 | -0.7% | 10.4% | 1,668,178 | 1,491,237 | 11.9% |
| 2022/03 | 433,700 | 394,959 | 34.4% | 9.8% | 1,237,368 | 1,101,105 | 12.4% |
| 2022/02 | 322,740 | 312,910 | -32.9% | 3.1% | 803,669 | 706,146 | 13.8% |
| 2022/01 | 480,929 | 393,236 | 0.2% | 22.3% | 480,929 | 393,236 | 22.3% |
| 2021/12 | 480,171 | 412,784 | 22.1% | 16.3% | 4,604,072 | 4,311,623 | 6.8% |
| 2021/11 | 393,206 | 340,793 | 9.3% | 15.4% | 4,123,901 | 3,898,839 | 5.8% |
| 2021/10 | 359,643 | 370,225 | -6.1% | -2.8% | 3,730,695 | 3,558,046 | 4.8% |
| 2021/09 | 382,901 | 359,392 | 0.9% | 6.5% | 3,371,052 | 3,187,821 | 5.7% |
| 2021/08 | 379,426 | 345,579 | 5.8% | 9.8% | 2,988,152 | 2,828,429 | 5.6% |
| 2021/07 | 358,516 | 340,386 | 13.6% | 5.3% | 2,608,726 | 2,482,850 | 5.1% |
| 2021/06 | 315,438 | 358,120 | -28.9% | -11.9% | 2,250,210 | 2,142,464 | 5% |
| 2021/05 | 443,535 | 379,591 | 13.7% | 16.8% | 1,934,772 | 1,784,344 | 8.4% |
| 2021/04 | 390,132 | 370,344 | -1.2% | 5.3% | 1,491,237 | 1,404,753 | 6.2% |
| 2021/03 | 394,959 | 393,137 | 26.2% | 0.5% | 1,101,105 | 1,034,408 | 6.4% |
| 2021/02 | 312,910 | 326,403 | -20.4% | -4.1% | 706,146 | 641,272 | 10.1% |
| 2021/01 | 393,236 | 314,869 | -4.7% | 24.9% | 393,236 | 314,869 | 24.9% |
| 2020/12 | 412,784 | 332,276 | 21.1% | 24.2% | 4,311,623 | 3,936,729 | 9.5% |
| 2020/11 | 340,793 | 345,724 | -7.9% | -1.4% | 3,898,839 | 3,604,453 | 8.2% |
| 2020/10 | 370,225 | 353,035 | 3% | 4.9% | 3,558,046 | 3,258,728 | 9.2% |
| 2020/09 | 359,392 | 369,659 | 4% | -2.8% | 3,187,821 | 2,905,693 | 9.7% |
生達(1720) 歷年營收季增率
| 年度/季別 | 營收季增率 | 近4季營收季增率 | 年度/季別 | 營收季增率 | 近4季營收季增率 |
|---|---|---|---|---|---|
| 2023Q2 | 1.07% | 0.45% | 2020Q3 | -5.66% | -0.08% |
| 2023Q1 | -5.73% | 4.37% | 2020Q2 | 7.12% | 2.36% |
| 2022Q4 | 2.24% | 6.38% | 2020Q1 | 0.33% | 4.78% |
| 2022Q3 | 4.58% | 8.44% | 2019Q4 | -1.68% | 0.81% |
| 2022Q2 | 19.71% | 7.01% | 2019Q3 | 3.74% | 3.77% |
| 2022Q1 | 0.35% | 2.96% | 2019Q2 | 19.46% | 2.93% |
| 2021Q4 | 10.01% | 2.43% | 2019Q1 | -15.33% | 2.32% |
| 2021Q3 | -2.46% | 1.71% | 2018Q4 | 10.21% | 2.55% |
| 2021Q2 | 4.36% | 0.94% | 2018Q3 | 0.32% | -3.94% |
| 2021Q1 | -2.02% | 1.55% | 2018Q2 | 18.42% | -1.99% |
| 2020Q4 | 7.50% | 2.20% | 2018Q1 | -16.19% | -3.83% |
評論0